Edward Allen Stadtmauer


Ontology type: schema:Person     


Person Info

NAME

Edward Allen

SURNAME

Stadtmauer

Publications in SciGraph latest 50 shown

  • 2022-03-29 CAR T cell therapy for multiple myeloma: What have we learned? in LEUKEMIA
  • 2022-02-10 Mass-Fix better predicts for PFS and OS than standard methods among multiple myeloma patients participating on the STAMINA trial (BMT CTN 0702 /07LT) in BLOOD CANCER JOURNAL
  • 2020-08-11 International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials in LEUKEMIA
  • 2020-06-18 Effect of malnutrition-driven nutritional support protocol on clinical outcomes in autologous stem cell transplantation patients in SUPPORTIVE CARE IN CANCER
  • 2020-04-14 Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation in BONE MARROW TRANSPLANTATION
  • 2018-05-24 Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract in BONE MARROW TRANSPLANTATION
  • 2016-07-29 Randomized phase III trial of consolidation therapy with bortezomib–lenalidomide–Dexamethasone (VRd) vs bortezomib–dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen in BLOOD CANCER JOURNAL
  • 2015-08-24 Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2015-07-20 NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma in NATURE MEDICINE
  • 2014-11-05 Classifying ultra-high risk smoldering myeloma in LEUKEMIA
  • 2014-07-21 Association between mobilization regimen and PFS after auto-SCT for multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2013-11-07 Adoptive immunotherapy with engineered T cells expressing and HLA-A2 restricted affinity-enhanced TCR for LAGE-1 and NY-ESO-1 in patients with multiple myeloma following auto-SCT in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2013-05-14 Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study in LEUKEMIA
  • 2013-05-06 Cellular immunotherapy for plasma cell myeloma in BONE MARROW TRANSPLANTATION
  • 2013-02-18 Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience in BONE MARROW TRANSPLANTATION
  • 2012-10-29 Trimming the fat: obesity and hematopoietic cell transplantation in BONE MARROW TRANSPLANTATION
  • 2012-04-02 Clinical outcomes of patients with desmoplastic small round cell tumor of the peritoneum undergoing autologous HCT: a CIBMTR retrospective analysis in BONE MARROW TRANSPLANTATION
  • 2012-02-06 High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT in BONE MARROW TRANSPLANTATION
  • 2011-11-14 Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance in BONE MARROW TRANSPLANTATION
  • 2010-05-24 Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD in BONE MARROW TRANSPLANTATION
  • 2010-05-03 Stem cell collection in patients with multiple myeloma: impact of induction therapy and mobilization regimen in BONE MARROW TRANSPLANTATION
  • 2009-11-27 Allogeneic Transplantation for the Treatment of Multiple Myeloma in ALLOGENEIC STEM CELL TRANSPLANTATION
  • 2009-07-23 Long-term follow-up on overall survival from the MM-009 and MM-010 phase III trials of lenalidomide plus dexamethasone in patients with relapsed or refractory multiple myeloma in LEUKEMIA
  • 2009-06-25 International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100) in LEUKEMIA
  • 2009-01-24 Chronic Lymphocytic Leukemia: New Concepts and Emerging Therapies in CURRENT TREATMENT OPTIONS IN ONCOLOGY
  • 2008-10-13 Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma in BONE MARROW TRANSPLANTATION
  • 2008-01-17 Efficacy and safety of bortezomib in patients with renal impairment: results from the APEX phase 3 study in LEUKEMIA
  • 2006-11-09 Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials in LEUKEMIA
  • 2006-06-12 Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2006-05-17 High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed in BONE MARROW TRANSPLANTATION
  • 2005-10-16 Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer in NATURE MEDICINE
  • 2005-10-03 Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma in BONE MARROW TRANSPLANTATION
  • 2005-03-14 Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2003-05-06 ‘GVHD’: graft-versus-host disease or graft-versus-Hodgkin's disease? an old acronym with new meaning in BONE MARROW TRANSPLANTATION
  • 2003-03 Consensus on Medical Treatment of Metastatic Breast Cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2003-03 High Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Breast Cancer: Is there a Place? in BREAST CANCER RESEARCH AND TREATMENT
  • 2003-02-01 Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer in BONE MARROW TRANSPLANTATION
  • 2003-02-01 Post-transplant lymphoproliferative disorder: a review in BONE MARROW TRANSPLANTATION
  • 2002-10 Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia in CURRENT ONCOLOGY REPORTS
  • 2002-07-12 Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin's lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalopathy in ANNALS OF HEMATOLOGY
  • 2002-07-01 Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease in BONE MARROW TRANSPLANTATION
  • 2002-07 High-Dose Chemotherapy and Stem Cell Support for Breast Cancer in DRUGS & AGING
  • 2002-04-08 High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer in BREAST CANCER
  • 2001-06-01 Effect of induction chemotherapy and tandem cycles of high-dose chemotherapy on outcomes in autologous stem cell transplant for metastatic breast cancer in BONE MARROW TRANSPLANTATION
  • 2000-01-01 Human herpesvirus 8 (KSHV) contamination of peripheral blood and autograft products from multiple myeloma patients in BONE MARROW TRANSPLANTATION
  • 2000 What Is the Role of Autologous Stem Cell Transplantation for Leukemia? in CURRENT CONTROVERSIES IN BONE MARROW TRANSPLANTATION
  • 1999-12 Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination in MEDICAL ONCOLOGY
  • 1999-09-01 Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 1998-12 Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder in MEDICAL ONCOLOGY
  • Affiliations

  • University of Pennsylvania (current)
  • Imperial College London
  • Centre Hospitalier Universitaire de Nantes
  • Cornell University
  • Peter MacCallum Cancer Centre
  • Memorial Sloan Kettering Cancer Center
  • Hackensack University Medical Center
  • National and Kapodistrian University of Athens
  • University Hospital Heidelberg
  • University of Rochester Medical Center
  • Tufts University
  • Hadassah Medical Center
  • University of Alberta
  • Medical College of Wisconsin
  • Juravinski Cancer Centre
  • Roswell Park Cancer Institute
  • University of Pennsylvania Health System
  • Queen's University
  • University of California, Los Angeles
  • Columbia University
  • Emory University
  • Takeda (United States)
  • University of Maryland, Baltimore
  • Children's Hospital of Philadelphia
  • NewYork–Presbyterian Hospital
  • Oregon Health & Science University
  • Complejo Hospitalario de Salamanca
  • Long Island Jewish Medical Center
  • Erasmus MC
  • City Of Hope National Medical Center
  • University of Salamanca
  • National Cancer Institute
  • Saskatchewan Cancer Agency
  • Queen Elizabeth II Health Sciences Centre
  • Generic Assays (Germany)
  • Hospital of the University of Pennsylvania
  • Eastern Cooperative Oncology Group
  • Central European Cooperative Oncology Group
  • Hôpital Claude Huriez
  • Sahlgrenska University Hospital
  • Centre Hospitalier Régional et Universitaire de Lille
  • The University of Texas MD Anderson Cancer Center
  • Yale University
  • University of Wisconsin–Madison
  • Princess Margaret Cancer Centre
  • University of Minnesota
  • University of Wrocław
  • Moffitt Cancer Center
  • Penn Presbyterian Medical Center
  • Indiana University Hospital
  • Dana-Farber Cancer Institute
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.25879.31", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.277151.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1055.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.51462.34", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239835.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5216.0", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5253.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412750.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.429997.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17788.31", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17089.37", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.30760.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.477522.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240614.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412701.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410356.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.19006.3e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.21729.3f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.189967.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419849.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411024.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.239552.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413734.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5288.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411258.b", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.273206.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410425.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.11762.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.419525.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413292.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.452429.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411115.1", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.428556.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.488232.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.413875.c", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.1649.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.410463.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240145.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.47100.32", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.14003.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415224.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17635.36", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8505.8", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.468198.a", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412713.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411570.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.65499.37", 
            "type": "Organization"
          }
        ], 
        "familyName": "Stadtmauer", 
        "givenName": "Edward Allen", 
        "id": "sg:person.01044042041.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_750.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01044042041.97'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01044042041.97'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01044042041.97'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01044042041.97'


     

    This table displays all metadata directly associated to this object as RDF triples.

    116 TRIPLES      10 PREDICATES      61 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01044042041.97 schema:affiliation Ne0b42cd78db94a9e8facb6552c78dca6
    2 grid-institutes:grid.1055.1
    3 grid-institutes:grid.11762.33
    4 grid-institutes:grid.14003.36
    5 grid-institutes:grid.1649.a
    6 grid-institutes:grid.17089.37
    7 grid-institutes:grid.17635.36
    8 grid-institutes:grid.17788.31
    9 grid-institutes:grid.189967.8
    10 grid-institutes:grid.19006.3e
    11 grid-institutes:grid.21729.3f
    12 grid-institutes:grid.239552.a
    13 grid-institutes:grid.239835.6
    14 grid-institutes:grid.240145.6
    15 grid-institutes:grid.240614.5
    16 grid-institutes:grid.273206.2
    17 grid-institutes:grid.277151.7
    18 grid-institutes:grid.30760.32
    19 grid-institutes:grid.410356.5
    20 grid-institutes:grid.410425.6
    21 grid-institutes:grid.410463.4
    22 grid-institutes:grid.411024.2
    23 grid-institutes:grid.411115.1
    24 grid-institutes:grid.411258.b
    25 grid-institutes:grid.411570.6
    26 grid-institutes:grid.412701.1
    27 grid-institutes:grid.412713.2
    28 grid-institutes:grid.412750.5
    29 grid-institutes:grid.413292.f
    30 grid-institutes:grid.413734.6
    31 grid-institutes:grid.413875.c
    32 grid-institutes:grid.415224.4
    33 grid-institutes:grid.419525.e
    34 grid-institutes:grid.419849.9
    35 grid-institutes:grid.428556.8
    36 grid-institutes:grid.429997.8
    37 grid-institutes:grid.452429.c
    38 grid-institutes:grid.468198.a
    39 grid-institutes:grid.47100.32
    40 grid-institutes:grid.477522.1
    41 grid-institutes:grid.48336.3a
    42 grid-institutes:grid.488232.7
    43 grid-institutes:grid.51462.34
    44 grid-institutes:grid.5216.0
    45 grid-institutes:grid.5253.1
    46 grid-institutes:grid.5288.7
    47 grid-institutes:grid.5386.8
    48 grid-institutes:grid.5645.2
    49 grid-institutes:grid.65499.37
    50 grid-institutes:grid.7445.2
    51 grid-institutes:grid.8505.8
    52 schema:familyName Stadtmauer
    53 schema:givenName Edward Allen
    54 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044042041.97
    55 schema:sdDatePublished 2022-08-04T17:38
    56 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    57 schema:sdPublisher N5cf3a9b2a8cd4680b58b8d02a5922f86
    58 sgo:license sg:explorer/license/
    59 sgo:sdDataset persons
    60 rdf:type schema:Person
    61 N5cf3a9b2a8cd4680b58b8d02a5922f86 schema:name Springer Nature - SN SciGraph project
    62 rdf:type schema:Organization
    63 Ne0b42cd78db94a9e8facb6552c78dca6 schema:affiliation grid-institutes:grid.25879.31
    64 sgo:isCurrent true
    65 rdf:type schema:OrganizationRole
    66 grid-institutes:grid.1055.1 schema:Organization
    67 grid-institutes:grid.11762.33 schema:Organization
    68 grid-institutes:grid.14003.36 schema:Organization
    69 grid-institutes:grid.1649.a schema:Organization
    70 grid-institutes:grid.17089.37 schema:Organization
    71 grid-institutes:grid.17635.36 schema:Organization
    72 grid-institutes:grid.17788.31 schema:Organization
    73 grid-institutes:grid.189967.8 schema:Organization
    74 grid-institutes:grid.19006.3e schema:Organization
    75 grid-institutes:grid.21729.3f schema:Organization
    76 grid-institutes:grid.239552.a schema:Organization
    77 grid-institutes:grid.239835.6 schema:Organization
    78 grid-institutes:grid.240145.6 schema:Organization
    79 grid-institutes:grid.240614.5 schema:Organization
    80 grid-institutes:grid.25879.31 schema:Organization
    81 grid-institutes:grid.273206.2 schema:Organization
    82 grid-institutes:grid.277151.7 schema:Organization
    83 grid-institutes:grid.30760.32 schema:Organization
    84 grid-institutes:grid.410356.5 schema:Organization
    85 grid-institutes:grid.410425.6 schema:Organization
    86 grid-institutes:grid.410463.4 schema:Organization
    87 grid-institutes:grid.411024.2 schema:Organization
    88 grid-institutes:grid.411115.1 schema:Organization
    89 grid-institutes:grid.411258.b schema:Organization
    90 grid-institutes:grid.411570.6 schema:Organization
    91 grid-institutes:grid.412701.1 schema:Organization
    92 grid-institutes:grid.412713.2 schema:Organization
    93 grid-institutes:grid.412750.5 schema:Organization
    94 grid-institutes:grid.413292.f schema:Organization
    95 grid-institutes:grid.413734.6 schema:Organization
    96 grid-institutes:grid.413875.c schema:Organization
    97 grid-institutes:grid.415224.4 schema:Organization
    98 grid-institutes:grid.419525.e schema:Organization
    99 grid-institutes:grid.419849.9 schema:Organization
    100 grid-institutes:grid.428556.8 schema:Organization
    101 grid-institutes:grid.429997.8 schema:Organization
    102 grid-institutes:grid.452429.c schema:Organization
    103 grid-institutes:grid.468198.a schema:Organization
    104 grid-institutes:grid.47100.32 schema:Organization
    105 grid-institutes:grid.477522.1 schema:Organization
    106 grid-institutes:grid.48336.3a schema:Organization
    107 grid-institutes:grid.488232.7 schema:Organization
    108 grid-institutes:grid.51462.34 schema:Organization
    109 grid-institutes:grid.5216.0 schema:Organization
    110 grid-institutes:grid.5253.1 schema:Organization
    111 grid-institutes:grid.5288.7 schema:Organization
    112 grid-institutes:grid.5386.8 schema:Organization
    113 grid-institutes:grid.5645.2 schema:Organization
    114 grid-institutes:grid.65499.37 schema:Organization
    115 grid-institutes:grid.7445.2 schema:Organization
    116 grid-institutes:grid.8505.8 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...